# Aktivo Labs

> Aktivo Labs is a Singapore-based digital health-science company that turns everyday smartphone and wearable data into a proprietary digital biomarker, the Aktivo Score, a 1-99 measure of an individual's risk for chronic disease. It sells its platform to life and health insurers, reinsurers and employers, helping them run evidence-based wellness programs and understand population health risk. Founded in 2017, the company raised a US$10M Series A led by Mitsui & Co. in 2022 and operates across Asia-Pacific with expansion into the US, Europe and Japan.

- **Founded:** 2017
- **Headquarters:** Singapore
- **Founders:** Gourab Mukherjee (Co-Founder & CEO), Meng-Han Kuok (Co-Founder), David Lai (Co-Founder (deceased))
- **Team size:** ~49-66 employees
- **Products:** Aktivo Score, Aktivo Mind, Glucolife, Goodbiome, Aktivo Platform
- **Notable:** Raised US$10M Series A led by Mitsui & Co. (2022), Developed the Aktivo Score, a proprietary 1-99 digital biomarker for chronic-disease risk, Built a multi-product health portfolio spanning cardiovascular risk, mental health, diabetes and gut microbiome

## Products & services

- **Aktivo Score** — A proprietary digital biomarker that quantifies chronic-disease risk into a 1-99 composite score, dynamically evaluating exercise, sedentary behavior and sleep by integrating with major wearables and health apps.
- **Aktivo Mind** — An app that digitizes aspects of Cognitive Behavioural Therapy for mental wellbeing.
- **Glucolife** — A diabetes-management app that includes fiber and nutritional scoring to support metabolic health.
- **Goodbiome** — Gut-microbiome and high-dimensional composition analysis that forms a core part of Aktivolabs' intellectual property.
- **Aktivo Platform** — A B2B/B2B2C digital health platform delivering aggregated population-health analytics and individualized health journeys to insurers, reinsurers and employers.

## Achievements

- Raised US$10M Series A led by Mitsui & Co. (2022)
- Developed the Aktivo Score, a proprietary 1-99 digital biomarker for chronic-disease risk
- Built a multi-product health portfolio spanning cardiovascular risk, mental health, diabetes and gut microbiome
- HIPAA, GDPR and ISO 27001 aligned data practices
- Expanded distribution via insurer partnerships across Asia-Pacific and into Africa

## Latest updates

- **2025-08** — Announced strategic alliance with South Africa's Lifecheq to bridge online wellness engagement and offline insurance distribution across Asia and Africa.
- **2023-10** — CEO Gourab Mukherjee presented at the ITC (InsureTech Connect) 3rd Annual Conference.
- **2022-12** — Closed US$10M Series A led by Mitsui & Co. to fuel data-science and geographic expansion.

## Links

- Website: https://aktivolabs.com
- LinkedIn: http://www.linkedin.com/company/aktivo-labs
- Twitter/X: https://twitter.com/aktivolabs
- Facebook: https://www.facebook.com/aktivolabs/

---

Profile page: https://yespress.io/aktivo-labs
Published by YesPress — https://yespress.io
Last updated: 2026-08-04